当前位置:循环首页>正文

[IHF2010]药物基因组学预测华法林的剂量——M.Lee专访

作者:  M.Lee   日期:2010/8/29 13:04:00

国际循环网版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。

<International Circulation>: Warfarin as a classical anticoagulant drug is widely used in clinical practice. If the dose of warfarin is excessive, hemorrhage may occur and if the dose of warfarin is insufficient, embolism may occur. So clinicians need to be careful and prudent in using warfarin. Predicting warfarin dosage using pharmacogenetic algorithms is more scientific and reasonable however this technique is still strange to many clinicians. Can you outline the measures involved in applying this technique?

    <International Circulation>: As many new anticoagulant drugs are being used today and constantly being developed, warfarin usage is threatened. Can predicting warfarin dose with pharmacogenetic algorithms resolve or reverse this trend and how? 
 
    Prof. Lee: Warfarin has been used for a long time, but as a consequence we know a lot about warfarin including safety. For new drugs which may claim to be better, we do not have the experience of usage we have with warfarin. An example would be the anticoagulant drug ximelagatran by AstraZeneca, which appeared on the market but was quickly withdrawn because it caused liver damage. So for every new drug, even though they may lower bleeding incidence, such as dabigatran by Boehringer Ingelheim, when you examine the trial results, it still causes bleeding and is still dose responsive. This tells

上一页  [1]  [2]  [3]  

版面编辑:沈会会  责任编辑:张衡



药物基因组学 华法林 剂量

分享到: 更多


设为首页 | 加入收藏 | 关于我们 | 联系方式 | 招贤纳士
声明:国际循环网( www.icirculation.com)对刊载的所有文章、视频、幻灯、音频等资源拥有全部版权。未经本站许可,不得转载。
京ICP备15014970号-5  互联网药品信息服务资格证书编号(京)-非经营性-2017-0063  京公网安备 11010502033353号  增值电信业务经营许可证:京ICP证150541号
国际循环 版权所有   © 2004-2024 www.icirculation.com All Rights Reserved
公司名称:北京美赞广告有限公司 公司地址:北京市朝阳区朝阳门北大街乙12号天辰大厦1座1409 电话:010-51295530